Genesis Healthcare, Pioneer of Genetic Test Service, Raises 1.65 Billion Yen Newly
Published: Feb 27, 2018 12:00 a.m. ET
TOKYO, Feb. 27, 2018 /PRNewswire/ -- Genesis Healthcare Co., Japan's pioneer genetic testing and research company, has completed a third-party equity allocation to Rakuten, Inc. and Omron Healthcare Co., Ltd. Genesis' Capital has increased to 3.78 billion yen, and Genesis' post-money valuation is approximately 42 billion yen (*1).
As the market leader in the genetic testing and research field in Japan, Genesis has actively pursued development of the Japanese scientific landscape through numerous R&D, product development, awareness raising via human resource development and advanced education, and genetic data translation into useful solutions.
This will be Rakuten's second investment since its initial investment in August 2017. Rakuten's commitment to assist in the development and advancement of genetic technology and its useful applications in healthcare is a novel approach to fostering innovation.
www.marketwatch.com/story/...eid=bigcharts&dist=bigcharts